Literature DB >> 18307986

Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease.

Beata Sarecka1, Iwona Zak, Jolanta Krauze.   

Abstract

OBJECTIVES: To assess the relationship between IL-6 and PAI-1 polymorphisms and coronary artery disease (CAD) and to observe the interactions between these polymorphic variants and smoking in the CAD risk. DESIGN AND
METHOD: The study population consisted of 178 patients with angiographically documented CAD and 202 blood donors. The analyses of genetic polymorphisms were performed using the PCR-RFLP method.
RESULTS: The frequency of PAI-1 5G allele was higher in the entire CAD group than in control group (p=0.04, OR=1.35). Also the 5G allele carriers (4G5G+5G5G) were more frequent in patients than in controls (p=0.03, OR=1.93). The number of women carrying 5G allele was again significantly higher among patients (OR=10.95 p=0.0075). The IL-6 C allele frequency was higher only in the CAD male subgroup (p=0.035, OR=1.44). We found synergistic and cumulative effects between specific genotype patterns and smoking in determining the risk of CAD, especially between PAI-1(4G5G+5G5G)+IL-6(CC) and smoking (SIM=4.18 and p=0.0005, OR=9.20, respectively).
CONCLUSIONS: There are synergistic and cumulative effects of 5G allele of PAI-1 polymorphism and C allele of IL-6 polymorphism with smoking in determining their associated risk with CAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307986     DOI: 10.1016/j.clinbiochem.2008.01.028

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

1.  PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.

Authors:  Zhongshu Liang; Weihong Jiang; Mao Ouyang; Kan Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis.

Authors:  Haifeng Hou; Chenglin Wang; Fengjing Sun; Linlin Zhao; Aishe Dun; Zheng Sun
Journal:  Inflamm Res       Date:  2015-07-15       Impact factor: 4.575

3.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

Authors:  Huifeng Zhang; Pingshuan Dong; Xuming Yang; Zhenghao Liu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 4.  Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.

Authors:  Samira Tabaei; Melodi Omraninava; Sahar Mehranfar; Morteza Motallebnezhad; Seyedeh Samaneh Tabaee
Journal:  Biochem Genet       Date:  2022-01-18       Impact factor: 2.220

5.  IL-6 gene polymorphisms and CAD risk: a meta-analysis.

Authors:  Yuan Yang; Fan Zhang; Laura Skrip; Han Lei; Yang Wang; Dayi Hu; Rongjing Ding
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

6.  Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease.

Authors:  Beata Sarecka-Hujar; Iwona Zak; Jolanta Krauze
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

7.  Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.

Authors:  Konstantinos Makrilakis; Kalliopi Fragiadaki; Jacqueline Smith; Petros P Sfikakis; George D Kitas
Journal:  Clin Rheumatol       Date:  2014-06-10       Impact factor: 2.980

8.  Gene polymorphism associated with TNF-α (G308A) IL-6 (C174G) and susceptibility to coronary atherosclerotic heart disease: A meta-analysis.

Authors:  Jiang Yuepeng; Xiaoxuan Zhao; Yang Zhao; Liu Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

9.  Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia.

Authors:  Emin Alioglu; Nurullah Tuzun; Fahri Sahin; Buket Kosova; Serkan Saygi; Istemihan Tengiz; Ugur Turk; Nazan Ozsan; Ertugrul Ercan
Journal:  Thromb J       Date:  2009-02-20

10.  The IL-6 rs1800795 and rs1800796 polymorphisms are associated with coronary artery disease risk.

Authors:  Shuai Lu; Ya Wang; Yijun Wang; Jing Hu; Wu Di; Shuangye Liu; Xiaohui Zeng; Guo Yu; Yan Wang; Zhaohui Wang
Journal:  J Cell Mol Med       Date:  2020-05-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.